Complete FDA and NHTSA recall records dated in 2020, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Product labels were applied to wrong product resulting in an undeclared fish allergen.
Product has potential to be contaminated with bacteria.
The firm received a recall notice for hardboiled eggs that were potentially contaminated with Listeria monocytogenes. The eggs were subsequently used to manufacture various salad and deli…
Product is recalled due to the potential presence of glyphosate.
Product containing a wing dipping sauce was incorrectly labeled as a barbeque dipping sauce. The product contained soy lecithin but the incorrect label does not declare the presence of soy.
Product is recalled due to the potential presence of glyphosate.
Product was recalled due to a potential for contamination with glyphosate.
The firm received a complaint from one of their customers that the product contained pieces of black plastic in the product.
11.8 ppm of glyphosate was detected in dry garbanzo beans.
The firm received a recall notice for hardboiled eggs that were potentially contaminated with Listeria monocytogenes. The eggs were subsequently used to manufacture various salad and deli…
Label declares ghee, but it does not declare milk.
Products contain undeclared soy.
Product has potential to be contaminated with bacteria.
The firm received a recall notice for hardboiled eggs that were potentially contaminated with Listeria monocytogenes. The eggs were subsequently used to manufacture various salad and deli…
The firm received a recall notice for hardboiled eggs that were potentially contaminated with Listeria monocytogenes. The eggs were subsequently used to manufacture various salad and deli…
cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.
Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)
Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)
Subpotent
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.
